Ash Access Technology
US-based Ash Access Technology innovates devices to treat and prevent vascular access-related diseases.
Founded
1983US-based Ash Access Technology innovates devices to treat and prevent vascular access-related diseases.
Founded in Lafayette, United States, Ash Access Technology is a medical device company dedicated to developing technologies and devices aimed at treating and preventing vascular access-related diseases. Their core mission is to enhance patient safety and efficacy in vascular access procedures. The company focuses on creating innovative solutions that address the clinical consequences of these conditions, thereby improving patient outcomes in the healthcare market.
Notable figures affiliated with Ash Access Technology include Dr. Stephen R. Ash, a nephrologist and serial inventor who serves as Chief Scientist, and Robert B. Truitt, the CEO known for his commercialization and fundraising expertise. The company has made significant strides in the medical field, benefiting numerous patients worldwide through their groundbreaking innovations. Their impact is evident in the improved safety and effectiveness of vascular access treatments, marking them as a key player in the medical device industry.
Companies similar to Ash Access Technology include Access Vascular, Bluegrass Vascular Technologies, Phraxis and Attwill Vascular Technologies.
Ash Access Technology was founded in 1983.
Ash Access Technology's headquarters is located in Lafayette, IN, US.
Ash Access Technology's most recent funding round was for $453k (USD) in June 2010.
As of Jun 4, 2010, Ash Access Technology has disclosed funding of $453k (USD). Undisclosed round amounts are excluded.
Ash Access Technology has 7 employees as of Feb 5, 2024.
Attwill Vascular Technologies
